• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Biogen’s latest board shake-up includes potentially controversial pick | BioPharma Dive





This will be a fun quote for hr interactions

" her personal matters are much less relevant than what she brings to this board."

When I was at biogen it was only the reps that slept together. Glad to see that such “personal matters” now extend to the board of directors. Way to keep it classy biogen.